Bookmark and Share

Pediatric Inflammatory Bowel Disease Center

Our Mission

  1. To provide outstanding comprehensive medical care to let children with IBD live a productive and healthy life.
  2. To help patients, their parents and healthcare providers understand IBD and the unique concerns specific to children along with the various possible treatment options.
  3. Provide cutting edge diagnostic and therapeutic treatment to our patients with IBD by collaborating with other Pediatric IBD Centers across North America to evaluate such technology and therapies in appropriate clinical trials for a coordinated effort to best determine the validity, safety and efficacy of these new options.
 

Contact Us

Pediatric IBD Center for an Appointment:
410-328-6749 during our normal business hours, 8:30am-5:00pm

Pediatric GI OnCall Physician for Patient Emergencies:
410-879-2818

For Healthcare Providers wishing to contact a Physician for direct consultation:
1-800-373-4111 or 410-328-1234.

IBD Center Locations

Patients are seen at the main University of Maryland Children’s Hospital, in the Pediatric Specialty Center found on the 5th floor, Rm N5W40, of the hospital.

Satellite clinics are also held at: 

  • Upper Chesapeake Medical Center Physician Pavilion II in Bel Air, Harford County
  • Baltimore Washington Medical Center, Aiello Center 203 Hospital Drive, Glen Burnie, Anne Arundel County
  • Mt. Washington Pediatric Hospital, Baltimore, Baltimore County

Research

Our Clinicians and Researchers are involved in clinical, translational and basic science research to better define the causes of IBD in children and to help identify better and newer treatments.  

Team Members

Director: Howard A. Kader, MD 

Pediatric Gastroenterologists Providing IBD Care 

Dietician  

  • Joanna Herman, RD, LDN

Pediatric Surgery 

 
  1. Pediatric IBD Registry
  2. Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS): The Search for New Genes
  3. A Phase I, Multicenter, Open-label, Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents with Ulcerative Colitis
  4. METHYLPREDNISOLONE IN ACUTE MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE FLARES – CLINICAL OUTCOMES OF TWICE A DAY VERSUS ONCE A DAY DOSING
  5. Interleukins in Pediatric Inflammatory Bowel Disease

Related Links

IBD Materials for Patients

CCFA Brochures

Patient/Family-focused Books

  • Your Child with Inflammatory Bowel Disease: A Family Guide for Caregiving. Baltimore, The Johns Hopkins University Press, 2010.

Heathcare Provider Literature

  • Pediatric Inflammatory Bowel Disease. New York; Springer Science+Business Media, LLC, 2008.

IBD Staff Publications

Howard A. Kader, MD 

  • Kader HA, Kaufman SS, Raynor SC, Young R, Vanderhoof J, Ruby EI, Mack DR. Introduction of 6-mercaptopurine in Crohn’s disease patients during the perioperative period: A preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr 1997; 25(1):93-97.
  • Kader HA, Mascarenhas MR, Piccoli DA, Stouffer NO, Baldassano RN. Experiences of 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 1999; 28:54-58.
  • Kader HA, Telega GW, Wenner WJ, Rand EB, Maller ES, Baldassano RN. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease. J Clin Gastro 2000; 30(4):409-413.
  • Kader HA, Mascarenhas MR, Verma R, Collins M, Ruchelli E, Baldassano RN. Colonic Inflammation Found at Diagnosis of Juvenile Retention Polyps in Pediatric Patients. Am J Gastroenterol 2000; 95(8):1990-1993.
  • Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR. “Prevalence of Factor G1691A (Leiden), Prothrombin G20210A and Methylene Tetrahydrofolate Reductase C677T Thrombophilic Mutations in Children with Inflammatory Bowel Disease”. J. Pediatr Gastroenterol Nutr 2002; 35(5):629-635.
  • Kader HA, Tchernev VT, Satyaraj E, Lejnine S, Kotler G, Kingsmore SF, Patel DD. Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-1 and IL-12p40 levels in Crohn’s Disease and Ulcerative Colitis Patients in Remission versus Active Disease. Am. J. Gastroenterol 2005; 100(2):414-423.
  • Colletti, RB, Baldassano, RN, Milov, DE, Margolis, PA, Bousvaros, A, Crandall, WV, Crissinger, KD, D’Amico, MD, Day, AS, Denson, LE, Dubinsky M, Ebach, DR, Hoffenberg, EJ, Kader, HA, Keljo, DJ, eibowitz, IA, Mamula, P, Pfefferkorn, MD, Qureshi, MA for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in Care in Pediatric Crohn’s Disease . J. Pediatr Gastroenterol Nutr. 2009;49(3):297-303.
  • Jacobstein D, Kader HA, Antibiotic Therapy, In: Mamula P, Markowitz JE and Baldassano RN eds. Pediatric Inflammatory Bowel Disease. New York; Springer Science+Business Media, LLC, 2008, 329-336.
  • Contributing author, Kader HA, Transitions from Pediatric to Adult Healthcare Provider. In: Oliva-Hemker M, Ziring D and Bousvaros A eds-in-chief. Your Child with Inflammatory Bowel Disease: A Family Guide for Caregiving. Baltimore; The Johns Hopkins University Press, 2010, 232-235.
  • Ming-Hsi Wang, MD, PhD, Toshihiko Okazaki, MD, PhD, Subra Kugathasan, MD, Judy H. Cho, MD, Kim L. Isaacs, MD, James D. Lewis, MD, Duane T. Smoot, MD, John F. Valentine, MD, Howard A. Kader, MD, Jean G. Ford, MD, Mary L. Harris, MD, Maria Oliva-Hemker, MD, Carmen Cuffari, MD, Michael S. Torbenson, MD, Richard H. Duerr, MD, Mark Silverberg, MD, PhD, John D. Rioux, PhD, Kent D. Taylor, PhD, Geoffrey C. Nguyen, MD, PhD, Yuqiong Wu, MD, Lisa W. Datta, MSc, Stanley Hooker, BS, Themistocles Dassopoulos, MD, Rick A. Kittles, PhD Linda W.H. Kao, PhD, Steven R. Brant, MD. Contribution of Higher Risk Genes and European Admixture to Crohn’s Disease in African Americans. Inflammatory Bowel Disease Journal. 2012;18(12):2277-2287
  • Kader, HA, Jacobstein D, Paul A, Antibiotic Therapy, In: Mamula P, Markowitz JE and Baldassano RN eds. Pediatric Inflammatory Bowel Disease, 2nd Ed. New York; Springer Science+Business Media, LLC, 2013, 289-294.

Anca Safta, MD  

  • Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J. Pediatr Gastroenterol Nutr. 2008; 47(1):61-7.

Anjali Malkani, MD  

  • Gelfond D, Blanchard SS, Malkani A. Pneumatosis Intestinalis: A Rare Presentation of Crohn Disease Exacerbation. J. Pediatr Gastrolenterol Nutr. 2011; 52(2):225-6.

Samra S. (Sarigol) Blanchard, MD  

  • Sarigol S, Caulfield M, Wyllie R. et al. "Ileal-Pouch Anal Anastomosis in Children with Ulcerative Colitis" Inflammatory Bowel Diseases, Vol 2(2):82-7, 1996.
  • Sarigol S, Wyllie R, Gramlich T, Alexander F, Fazio V, Kay M, Mahajan L. Incidence of dysplasia in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis.
  • J Pediatr Gastroenterol Nutr 28:429-34, 1999.
  • Sarigol S, Wyllie R, Gramlich T, Mahajan L, Kay M. Inflammatory bowel disease presenting as salmonella colitis: the importance of histologic evaluation in the recognition and management. Clin Pediatr; 38 (11):669-71, 1999.
  • Alexander F, Sarigol S, Difiore J, Stallion A, Cotman K, Lyk Hdzinski B, Fazio V. Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg. 38(1):78-82, 2003.
  • Gelfond D, Blanchard SS, Malkani A. Pneumatosis Intestinalis: A Rare Presentation of Crohn Disease Exacerbation. J. Pediatr Gastrolenterol Nutr. 2011; 52(2):225-6.